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In the latter half of the 20th century, there has been such an
increase in the prevalence of asthma in developed countries
that it has been characterized as an ‘asthma epidemic,’
although part of the increase may be due to increased aware-
ness of the symptoms of asthma and increased rates of
reporting (1). There have been numerous studies investigating
possible explanations for the increase but much remains
unknown about the causes of asthma. Pregnancy is increas-
ingly recognized as a time in which genes are activated or
silenced. Such epigenetic programming can determine an indi-
vidual’s susceptibility to a wide range of clinical conditions.
Study of early-life events is important both for an under-
standing of childhood asthma itself and of adult asthma (2).
In addition to biologic factors such as parental history of
asthma and male sex, childhood asthma is associated with
environmental exposures and socio-economic factors. Poten-
tial risk factors speciﬁcally related to the delivery and neona-
tal period include prematurity, fetal growth restriction, and
mode of delivery (3). Increased risk of childhood asthma may
begin as early as an in utero exposure to maternal ascending
infection, chorioamnionitis, and antibiotics that may lead to
epigenetic changes in the fetus (4–7).
Large population-based studies using longitudinally linked
population health databases enable the analysis of many
potential perinatal risk factors for childhood asthma with
sufﬁcient numbers of events to minimize the chance of miss-
ing signiﬁcant associations. The study of hospital admissions,
representing inadequately controlled asthma and the severe
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Abstract
Background: There is increasing interest in the potential for in utero exposures to
affect the risk of asthma. We used population data to explore the associations
between perinatal conditions and the risk of hospital admission with asthma
between the 2nd and 5th birthday.
Methods: The study population was 240,511 singleton infants born during 2001–
2003. Birth records and longitudinally linked hospital admissions were used to iden-
tify asthma admissions and to model potential risk factors.
Results: A total of 7245 children (3.0%) had one or more childhood admissions
with asthma. In utero infectious exposures associated with childhood asthma were
maternal antenatal admission with a urinary tract infection (UTI) [adjusted odds
ratio (aOR) = 1.49, 95% conﬁdence interval (1.23–1.79)] and pre-term pre-labor
rupture of membranes (PROM) [aOR = 1.23 (1.04–1.45)]. There was no evidence
that gestational age at time of ﬁrst antenatal UTI admission (<28, ‡28 wks)
affected the risk of asthma (homogeneity test p = 0.6). Pre-term birth was a risk
factor for asthma admission, with the risk decreasing by 5.3% with each extra week
of gestation. Autumn and winter conceptions were associated with an increased risk
of childhood asthma admission: winter aOR = 1.15 (1.08–1.23), autumn
aOR = 1.09 (1.02–1.16).
Conclusions: As in utero exposure to both UTI and PROM carry an increased risk
of childhood asthma admission, this suggests that the immune system response gen-
erally is the relevant factor rather than a speciﬁc organism. The season-associated
risk is consistent with early pregnancy exposures such as the winter ﬂu season or
low vitamin D.
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ticularly beneﬁts from the availability of population data.
Our aim was to develop a multivariable risk factor model of
asthma hospitalization and to use the model to explore the
strength of association with risk factors from the pregnancy
and neonatal period.
Methods
All singleton births to residents of New South Wales (NSW)
Australia from 1 January 2001 through 31 December 2003
who survived to at least 2 yrs of age were included in the
study population. Data were available from longitudinally
linked population datasets: the Admitted Patient Data Col-
lection, a database of all public and private hospital admis-
sions in NSW, and the Midwives Data Collection that
collects information on all births and is completed by the
attending midwife or obstetrician. Information on infant
cause of death was available through linkage to the Austra-
lian Bureau of Statistics (ABS) mortality data. As Australia
does not have a unique registration number for citizens, the
separate datasets were linked using probabilistic linkage
methods. This involves a process of blocking and matching
combinations of selected variables such as name, date of
birth, address, and hospital and assigning a probability
weight to the match. The validity of the probabilistic record
linkage is extremely high with <1% of records having an
incorrect match (8). The linked records were made available
as de-identiﬁed data. Use of the data was approved by the
NSW Population and Health Services Research Ethics Com-
mittee.
An admission was counted as an asthma-related admission
if any of 20 diagnosis ﬁelds on a discharge record contained
an International Classiﬁcation of Diseases 10 (ICD-10) code
for asthma (J45 or J46). Because of the uncertainty surround-
ing a diagnosis before the age of 24 months, hospital admis-
sions for asthma before this age were not counted.
Childhood hospitalizations were followed until the 5th birth-
day. All linked maternal discharge summaries (July 2000 to
June 2009) were used to identify conditions speciﬁc to the
pregnancy and also any maternal admission with an asthma
code at any time during the study period.
Potential perinatal risk factors
Maternal hypertension and maternal diabetes (including
chronic and gestational for each condition) were identiﬁed
from either the hospital discharge summaries or the birth
record. Season of conception was calculated by subtracting
the gestational age from the date of birth but adding 2 wks
as an average time from last menstrual period to conception.
Urinary tract infection (UTI) admissions were identiﬁed on
the discharge summaries and included diagnoses of pyelone-
phritis and cystitis. Pre-labor rupture of membranes (PROM)
was further categorized as term or pre-term (<37 wks gesta-
tion). Gestational age and small-for-gestational-age (SGA:
<10th percentile birthweight for gestational age and sex)
were included to represent the two underlying causes of low
birthweight: prematurity and intrauterine growth retardation.
Large-for-gestational-age (LGA: >90th percentile) was also
included. Gestational age, mode of delivery, and labor induc-
tion were available from the birth record. Neonatal respira-
tory distress syndrome, transient tachypnea, sepsis, and
jaundice were identiﬁed from the hospital discharge summa-
ries. We used a combined exposure indicator for jaundice
and/or phototherapy (9).
Maternal and environmental factors of indeterminate timing
Environmental and some maternal socio-economic and health
factors may affect pregnancy exposure but may also be prox-
ies for childhood environmental exposures. For example,
maternal smoking during the pregnancy has a bearing on
whether the child is likely to grow up in a smoking house-
hold, and urban/rural differences could affect both pregnancy
and childhood environments. Data on the birth record
included smoking in pregnancy, parity, and maternal age. A
socio-economic score was assigned to maternal postcode
using the 2006 Socioeconomic Index for Areas (http://
www.abs.gov.au) and then classiﬁed into quintiles. Residence
at time of birth was categorized as urban or rural based upon
the Accessibility/Remoteness Index of Australia score.
Analysis
Crude relative risks (RR) and 95% conﬁdence interval (95%
CI) were calculated for each potential risk factor, for all
births. Statistical evidence of a difference between two sub-
group RR’s was assessed using a chi-square test for homoge-
neity of effect. A hierarchical multilevel model was used to
calculate adjusted odds ratios (aOR), simultaneously adjust-
ing for all perinatal factors, using SAS’s GLIMMIX proce-
dure. A multilevel model takes into account that mothers
within geographic areas may share environmental exposures
and attend the same hospitals. The area-level grouping for
this study was the ABS statistical local area. Season of con-
ception and season of birth could not both be included in the
regression model because of their direct correlation. Season
of conception was selected for inclusion on the basis that this
is the antecedent event. Gestational age in weeks was
included as a continuous variable. Records with missing data
(0.13%) were excluded from the regression model.
Results
There were 244,878 eligible birth records but 4367 (1.8%),
did not link to any hospital admission. This left 240,511
infants in the birth cohorts, among whom there were 7245
(3.0%) with at least one asthma admission between their 2nd
and 5th birthday. The total number of admissions was
11,242; 5041 children had one admission, and 2204 had two
or more admissions. The majority (69%) of the admissions
were overnight or day only, but 1% of admissions were for
6 days or more and 126 (1.7%) children spent time in an
intensive care unit. Most admissions (80%) were to a public
hospital. There were two deaths in the birth cohort for whom
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aged <1 yr with asthma listed as a contributing cause but
were not included in the study cohorts because the deaths
occurred before the minimum 2 yrs. There were 2963 children
(1.2%) admitted with an asthma diagnosis at <2 yrs who
then had no subsequent asthma admission and thus were not
counted as cases in this analysis. Of the 7245 children admit-
ted at ‡2 yrs, 1115 (27.3%) had also been admitted with an
asthma diagnosis prior to their 2nd birthday.
Table 1 shows the crude RR for potential risk factors of
an infant being admitted with asthma before 5 yrs of age. A
history of any maternal admission with asthma doubled the
risk of asthma in the child. Of the 217,387 mothers, 8326
(3.5%) had one or more admissions with asthma during the
study period. The subgroup of 1453 women with two or
more admissions had a risk of a child with an asthma admis-
sion of RR = 2.28 (1.87–2.77). There was a clear relation-
ship between prematurity and risk of asthma admission, and
for births £31 wks gestation, the risk was approximately
triple. Even at term, there was an increased risk associated
with birth before 40 wks gestation (RR = 1.11) that was
important because 20% of births occurred at 37 through
38 wks gestation.
We analyzed the risk of ever being admitted for asthma in
relation to season and found evidence of seasonal variation.
By estimated month of conception, with summer as the refer-
ent season, the risk of childhood asthma admission for con-
ceptions in other seasons was as follows: spring RR = 1.03
(0.97–1.10), autumn RR = 1.09 (1.02–1.16), and winter
RR = 1.15 (1.08–1.23). By month of birth, with winter as
the referent season, the risk for other birth seasons was as
follows: spring RR = 0.99 (0.93–1.06), summer RR = 1.09
(1.02–1.17), and autumn RR = 1.13 (1.06–1.20).
Women with any antenatal UTI admission(s) were further
categorized into subgroups by whether the ﬁrst admission
was before 28 wks (ﬁrst two trimesters of pregnancy) or not.
Women with a UTI before 28 wks gestation had RR = 1.73
(1.33–2.33) of a child with an asthma admission compared
with women with no UTI admission, and women with a ﬁrst
UTI admission at ‡28 wks had RR = 1.58 (1.26–2.00); there
was no evidence of a difference (homogeneity chi square
p = 0.6). We also explored a potential dose–response to
antenatal UTI. Women with two or more antenatal UTI
admissions in the same pregnancy had children with
RR = 2.51 (1.66–3.78) of later asthma admission compared
with women without a UTI admission; women with only one
antenatal UTI admission had RR = 1.54 (1.27–1.86). The
test of homogeneity showed borderline evidence (p = 0.04)
of a difference in effect.
Table 2 shows the adjusted risks from the logistic regres-
sion model of childhood asthma admission. For parity, any
women with a previous birth were combined into one referent
category, resulting in a non-signiﬁcant RR = 0.97 (0.92–
1.02) for ﬁrst-born infants. For the socio-economic indicator,
the lower three quintiles were combined into one referent cat-
egory. The two most afﬂuent socio-economic quintiles
remained protective after adjustment for other factors. Gesta-
tional age was included as a continuous variable; the
aOR = 0.947 means that the risk decreased by 5.3% (95%
CI 3.8–6.7%) for each extra week of gestation. The crude
risk ratio for most factors changed by £10% after adjustment
in the model. The two strongest risk factors, maternal asthma
admission and male child, had adjusted risks that were
almost unchanged from their crude RR’s. Factors for which
the adjusted risk decreased by >10% included pre-term
PROM, transient tachypnea, respiratory distress syndrome,
neonatal sepsis, and jaundice/phototherapy. The risk for neo-
natal sepsis dropped from the crude RR = 1.99 to an
aOR = 1.20 with a conﬁdence interval that included unity.
Discussion
In our large population-based study, we ﬁnd that an
increased risk of asthma admission in children is associated
with birth factors including in utero exposures, even after
adjustment for other maternal and pregnancy factors. Among
the factors related to birth, the largest increases in risk are
associated with pre-term birth and with fetal exposure to
maternal UTI and PROM. Previous ﬁndings on pre-term
birth have been mixed but a meta-analysis did ﬁnd an overall
association with childhood asthma (10). Both pre-term birth
and rupture of membranes may be triggered by intrauterine
infection and resultant chorioamnionitis (11), so that all these
factors are inter-related. Intrauterine infections have sepa-
rately been reported to be associated with increased risk of
childhood asthma (4–6). That both maternal UTI and
PROM are associated with an increased risk of childhood
asthma in our population suggests that the risk associated
with maternal infection is not organism-speciﬁc but may be
related to the inﬂammatory response generally. The most
common microbe responsible for UTI is Escherichia coli,a n
organism not commonly found as an intrauterine pathogen
(4).
The antenatal period is a critical window for programming
of epigenetic changes (12), and both maternal UTI and any
infection associated with PROM may have multiple effects
on the fetus related to in utero infection, bacterial coloniza-
tion, and exposure to inﬂammatory cytokines. The timing of
UTI exposure in pregnancy did not appear to be critical in
our study population as the point estimate for ﬁrst UTI
admission at <28 wks is not signiﬁcantly different to that
for ﬁrst UTI at ‡28 wks. There is borderline evidence of a
dose–response association, as we found that women with two
or more antenatal UTI admissions have a greater risk of
asthma admission for their child. An apparent dose–response
relation has been reported between in utero exposure to anti-
biotic treatment and subsequent asthma (6), and maternal
UTI treated with antibiotics has also been associated with
transient early wheezing (7). The point estimate for the
adjusted risk associated with pre-term PROM in our study is
more than triple that for term PROM (aOR = 1.23 vs.
aOR = 1.06), suggesting that timing or duration of exposure
to ruptured membranes may contribute to an increased risk
of asthma. A recent study has reported that duration of rup-
tured membranes before birth is positively associated with
the prevalence of wheezing at 18 months of age (13). During
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Maternal/pregnancy/delivery factor Infant asthma admissions/n Crude relative risk RR (95% CI)
Maternal asthma admission* 508/8326 2.10 (1.93–2.30)
Maternal age (yrs)
<20 381/10,210 1.25 (1.13–1.38)
20–34 5518/185,315 1.0 (referent)
‡35 1346/44,883 1.01 (0.95–1.07)
Parity
Nulliparous (ﬁrst child) 3018/100,115 1.01 (0.96–1.07)
Parity = 1 2473/81,462 1.02 (0.96–1.08)
Parity ‡ 2 1749/58,762 1.0 (referent)
Smoked during pregnancy 1308/38,468 1.16 (1.09–1.23)
Urban area resident 5146/164,667 1.13 (1.07–1.19)
Area socio-economic percentile
>80th (most advantaged) 1360/49,008 0.87 (0.81–0.93)
>60th to 80th percentile 1360/47,297 0.90 (0.84–0.96)
40th to 60th percentile 1568/48,914 1.0 (referent)
20th to <40th percentile 1441/47,770 0.94 (0.88–1.01)
<20th (most disadvantaged) 1512/47,440 0.99 (0.93–1.07)
Any maternal diabetes 434/13,107 1.01 (1.00–1.22)
Any maternal hypertension 782/23,992 1.09 (1.02–1.17)
Season of conception
Autumn 1796/58,445 1.09 (1.02–1.16)
Winter 1980/60,943 1.15 (1.08–1.23)
Spring 1745/59,908 1.03 (0.97–1.10)
Summer 1724/61,175 1.0 (referent)
Antenatal admit UTI 123/2499 1.64 (1.38–1.96)
Rupture of membranes
Pre-term PROM 189/3453 1.85 (1.61–2.13)
Term PROM 559/17,402 1.09 (1.00–1.18)
No PROM 6497/219,656 1.0 (referent)
Gestational age (wks)
£31 126/1459 3.11 (2.62–3.68)
32–33 88/1466 2.16 (1.76–2.65)
34–36 364/9303 1.41 (1.27–1.57)
37–39 3225/104,369 1.11 (1.06–1.17)
‡40 3442/123,875 1.0 (referent)
Induction with prostaglandins 812/27,708 0.97 (0.90–1.04)
Mode of delivery
Cesarean section 1901/59,073 1.09 (1.04–1.15)
Instrumental 783/25,864 1.03 (0.96–1.11)
Normal vaginal 4560/155,533 1.0 (referent)
Male infant 4661/124,114 1.69 (1.61–1.77)
Birthweight percentile
SGA (<10th percentile) 805/24,118 1.12 (1.04–1.20)
10th–90th 5721/191,604 1.0 (referent)
LGA (>90th percentile) 719/24,746 0.97 (0.90–1.05)
Respiratory distress syndrome 193/3062 2.12 (1.85–2.44)
Transient tachypnea 306/7271 1.41 (1.26–1.58)
Jaundice and/or phototherapy 548/12,831 1.45 (1.33–1.58)
Neonatal bacterial sepsis 57/957 1.99 (1.54–2.56)
LGA, large-for-gestational-age’ PROM, pre-labor rupture of membranes; SGA, small-for-gestational-age.
*Mother was admitted with asthma anytime between July 2000 and June 2009.
Urinary tract infection.
Spontaneous pre-labor rupture of membranes.
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received antibiotics (14) including multiple courses if delivery
did not occur until weeks after PROM, although this does
not ensure eradication or prevention of intra-amniotic infec-
tion (15). Importantly, follow-up of the ORACLE I placebo-
controlled trial (antibiotics for pre-term PROM) found no
difference in parent-reported wheezing at 7 yrs of age by
antibiotic treatment exposure (16). Follow-up of the ORA-
CLE II trial (antibiotics for pre-term labor with intact mem-
branes) similarly found no increased risk by antibiotic
exposure (17). This supports the hypothesis that it is infection
rather than the antibiotics prescribed for treatment that is
responsible for the asthma risk.
There is a seasonal association with the risk of childhood
asthma in our birth cohorts. The association exists both by
month of conception and by month of delivery. By season of
conception, the highest seasonal risk was for winter
(aOR = 1.15), and by season of birth, the highest risk was
autumn (aOR = 1.13). One possible explanation for varia-
tion by season of conception may be reduced sun exposure
during the ﬁrst trimester of pregnancy resulting in lower lev-
els of vitamin D. In utero vitamin D deﬁciency has been
hypothesized to be a risk factor for asthma (18). Another
possible explanation is that women who conceive in autumn
or winter are exposed to the peak ﬂu season in their ﬁrst tri-
mester. Maternal infectious disease in pregnancy, including
febrile disease, has been associated with increased risk of
asthma at age 7 (19), although another study found no asso-
ciation between self-reported febrile disease in the 2nd and
3rd trimester of pregnancy and wheeze in the child during
the ﬁrst 2 yrs (20). By month of birth, the peak increase in
asthma risk is for autumn (RR = 1.13), and the direction of
this effect is consistent with a report that birth 4 months
before the winter virus peak season had aOR = 1.29 (1.19–
1.40) of childhood hospitalization with asthma (21) Concep-
tion and delivery are inextricably linked; a birth 4 months
before mid-winter implies a winter conception. Our data do
not permit us to determine which of the exposure windows is
the more relevant. However, reports that cytokine responses
and Immunoglobulin E levels from neonatal cord blood
showed seasonal variation suggests that at least some of the
seasonal exposure occurs in utero (22, 23).
Respiratory distress syndrome and transient tachypnea are
both independent neonatal risk factors for later asthma hos-
pitalization in our study although the strength of association
did moderate after adjustment for other factors such as gesta-
tional age. Transient tachypnea, which is nominally a tempo-
rary condition of the newborn, carries an aOR = 1.20 of
asthma admission. The direction of this effect is consistent
with the aOR = 1.50 (1.13–1.99) reported by a nested case–
control study.
An interesting ﬁnding in our study is that being a ﬁrst-
born child (a nulliparous mother) does not result in an
increased risk of childhood hospitalization for asthma. This
appears opposed to the protective effect of older siblings pos-
ited by the hygiene hypothesis but may simply reﬂect that
hospitalization with asthma is not the same outcome as diag-
nosis by primary care providers. Colds, ﬂu, and sinus infec-
tions are predictors of uncontrolled asthma (24), and it may
be that any protective effect that could be attributed to the
hygiene hypothesis is more than offset by an increased risk of
an RTI when there are siblings. Higher socio-economic status
is associated with reduced asthma hospitalization in our
study population, and this may be related to better control of
asthma as much as to variations in prevalence. A UK study
found a similar protective effect for children (aged ‡2 yrs) of
families in the top two social classes: aOR = 0.81 (0.74–0.89)
of hospital admission with asthma (25).
A strength of our study is that it is population-based and
has a clearly deﬁned dichotomous outcome (hospital admis-
sion) and that validated exposure factors (26, 27) were deter-
mined at the time of pregnancy and delivery and so were
unbiased by subsequent asthma status in the children. A limi-
tation to its generalizability is that the outcome represents
Table 2 Adjusted odds ratios (aOR) for admission to hospital with
asthma between 2 and 5 yrs of age (simultaneous adjustment for
all listed factors in the entire table)
aOR of asthma
admission (95% CI)
Maternal and environmental factors
Maternal asthma admission* 2.09 (1.90–2.29)
Maternal age <20 yrs 1.20 (1.07–1.34)
Maternal age ‡35 yrs 1.00 (0.94–1.07)
Nulliparous (ﬁrst child) 0.97 (0.92–1.02)
Smoked during pregnancy 1.08 (1.02–1.15)
Urban area resident 1.18 (1.10–1.26)
Most advantaged socio-economic quintile 0.87 (0.80–0.95)
2nd advantaged socio-economic quintile 0.92 (0.86–0.99)
Pregnancy and delivery factors
Spring conception 1.03 (0.96–1.10)
Autumn conception 1.09 (1.02–1.16)
Winter conception 1.15 (1.08–1.23)
Antenatal admit UTI 1.49 (1.23–1.79)
Any maternal diabetes 0.95 (0.86–1.06)
Any maternal hypertension 1.02 (0.95–1.11)
Pre-term PROM 1.23 (1.04–1.45)
Term PROM 1.06 (0.97–1.16)
Induction with prostaglandins 1.05 (0.97–1.13)
Cesarean section delivery 1.03 (0.97–1.09)
Infant factors
Male 1.70 (1.62–1.79)
Gestational age (per additional week) 0.947 (0.93–0.96)
SGA (<10th percentile size) 1.08 (1.00–1.17)
LGA (>10th percentile size) 0.97 (0.89–1.05)
Respiratory distress syndrome 1.34 (1.12–1.60)
Transient tachypnea of newborn 1.20 (1.07–1.36)
Jaundice and/or phototherapy 1.10 (0.99–1.22)
Neonatal bacterial sepsis 1.20 (0.90–1.60)
LGA, large-for-gestational-age; PROM, pre-labor rupture of mem-
branes; SGA, small-for-gestational-age.
*Mother was admitted with asthma anytime between July 2000
and June 2009.
Urinary tract infection
Spontaneous pre-labor rupture of membranes.
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asthma, rather than all children with asthma. Asthma pheno-
types could not be characterized, as we did not have informa-
tion on the medications used for control. Hospital
admissions can include a heterogenous mixture of children
with chronic asthma and those with infrequent acute episodes
(28). Our study population is recent, and so the ﬁndings are
relevant to current obstetric practices, but follow-up does not
extend beyond the 5th birthday. A further limitation is that
maternal medical data outside of hospital was not available.
Infections and antibiotic treatment are not uncommon in
pregnancy but do not generally result in hospital admission.
In an English pregnancy cohort, 42.2% of women reported
an infection and 35.1% reported use of antibiotics (6). The
theoretically unexposed comparison groups for UTI and
PROM exposures in our study probably included women
who had less severe UTI’s treated out of hospital, or who
had subclinical chorioamnionitis, or who had received antibi-
otics for other infections. The likely, but not certain, result of
such misclassiﬁed exposure would be that our reported risks
underestimate the true risks for potential fetal infectious
exposures. Maternal asthma status could not be fully ascer-
tained from our data. An Australian single-hospital study
found that in a sample of women attending for antenatal
care, 12.7% reported asthma and 7.8% used airway medica-
tions (29) in comparison with the 3.5% of mothers in our
study identiﬁed as having a history of admission with
asthma. It is likely that fewer than half of women on asthma
medication would have been identiﬁed based upon admission
history, and that the women with admissions may introduce
some selection bias into the adjusted model of asthma risk. A
further limitation is that other factors of interest such as
breastfeeding and paternal asthma were not available in our
datasets.
In summary, our large population-based study strengthens
the case that birth exposures are associated with childhood
asthma and suggests that increased risk may begin with fetal
exposures to a range of maternal infections. An intriguing
question is whether the seasonal inﬂuence on risk of develop-
ing childhood asthma could be related to either early preg-
nancy exposure to the winter ﬂu season or to low winter
levels of vitamin D.
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